Industry Presentations

Applying Molecular Technologies for Precision Prostate Cancer Care


Presentations


Speakers

  • Robert Dreicer, M.D., M.S., MACP, FASCO

    Robert Dreicer, M.D., M.S., MACP, FASCO

    Robert Dreicer, M.D., M.S., MACP, FASCO

    Head of Medical Oncology

  • David Morris, MD, FACS

    David Morris, MD, FACS

    David Morris, MD, FACS

    President, Co-Director

  • Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Medical Director, CPI

    Neal Shore, MD, is the Medical Director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr. Shore has conducted more than 400 clinical trials, focusing on GU Oncology indications. He is the Chief Medical Officer, Surgery/Urology, for GenesisCare,US. Dr. Shore serves on the SITC Guidelines Committee for Bladder Cancer and the boards of the Bladder Cancer Advocacy Network and the Duke Global Health Institute. He is the Chair of the LUGPA Education Committee. Dr. Shore is on the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE, Urology Practice, World Journal of Urology, and serves as Editor for Everyday Urology-Oncology. Also, he’s a Fellow of the American College of Surgeons.